Daniel P. van Plew - 04 Nov 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/**Daniel P. Van Plew
Issuer symbol
REGN
Transactions as of
04 Nov 2022
Net transactions value
-$11,847,569
Form type
4
Filing time
08 Nov 2022, 15:00:44 UTC
Previous filing
13 Sep 2022
Next filing
25 Nov 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $12,985,280 +34,000 +111% $381.92 64,578 04 Nov 2022 Direct
transaction REGN Common Stock Tax liability $18,954,586 -26,114 -40% $725.84 38,464 04 Nov 2022 Direct
transaction REGN Common Stock Sale $74,279 -100 -0.26% $742.79 38,364 07 Nov 2022 Direct
transaction REGN Common Stock Sale $817,729 -1,100 -2.9% $743.39 37,264 07 Nov 2022 Direct F1
transaction REGN Common Stock Sale $1,513,048 -2,032 -5.5% $744.61 35,232 07 Nov 2022 Direct F2
transaction REGN Common Stock Sale $1,094,409 -1,468 -4.2% $745.51 33,764 07 Nov 2022 Direct F3
transaction REGN Common Stock Sale $2,076,930 -2,782 -8.2% $746.56 30,982 07 Nov 2022 Direct F4
transaction REGN Common Stock Sale $301,869 -404 -1.3% $747.20 30,578 07 Nov 2022 Direct F5
holding REGN Common Stock 1,065 04 Nov 2022 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -34,000 -100% $0.000000* 0 04 Nov 2022 Common Stock 34,000 $381.92 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents volume-weighted average price of sales of 1,100 shares of Company stock on November 7, 2022 at prices ranging from $743.00 to $743.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2022 at each separate price.
F2 Represents volume-weighted average price of sales of 2,032 shares of Company stock on November 7, 2022 at prices ranging from $744.02 to $744.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2022 at each separate price.
F3 Represents volume-weighted average price of sales of 1,468 shares of Company stock on November 7, 2022 at prices ranging from $745.00 to $745.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2022 at each separate price.
F4 Represents volume-weighted average price of sales of 2,782 shares of Company stock on November 7, 2022 at prices ranging from $746.15 to $746.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2022 at each separate price.
F5 Represents volume-weighted average price of sales of 404 shares of Company stock on November 7, 2022 at prices ranging from $747.00 to $747.43. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 7, 2022 at each separate price.
F6 The stock option award vests in four equal annual installments, commencing one year after the date of grant.